Brooks O'Neil
Stock Analyst at Lake Street
(0.53)
# 4,174
Out of 5,116 analysts
34
Total ratings
23.53%
Success rate
-20.55%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXG MiMedx Group | Maintains: Buy | $12 → $10 | $5.11 | +95.69% | 2 | Jan 20, 2026 | |
| LFMD LifeMD | Maintains: Buy | $14 → $8 | $3.24 | +146.91% | 4 | Nov 18, 2025 | |
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $19.89 | -39.67% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.41 | +81.41% | 7 | Aug 11, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $1.92 | +941.67% | 2 | Apr 21, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $84.97 | +29.46% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $13.83 | +116.92% | 1 | Feb 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $5.30 | +390.57% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $40.94 | +34.34% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $14.83 | +21.38% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $9.78 | +104.50% | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.00 | +25.00% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $29.87 | -12.96% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.45 | +2,339.02% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $26.96 | +372.92% | 1 | Sep 15, 2020 |
MiMedx Group
Jan 20, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.11
Upside: +95.69%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $3.24
Upside: +146.91%
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $19.89
Upside: -39.67%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.41
Upside: +81.41%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $1.92
Upside: +941.67%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $84.97
Upside: +29.46%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $13.83
Upside: +116.92%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $5.30
Upside: +390.57%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $40.94
Upside: +34.34%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $14.83
Upside: +21.38%
Aug 9, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $9.78
Upside: +104.50%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.00
Upside: +25.00%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $29.87
Upside: -12.96%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.45
Upside: +2,339.02%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $26.96
Upside: +372.92%